You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Moodys
Harvard Business School
Baxter
McKesson

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Drugs in MeSH Category Potassium Channel Blockers


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wockhardt AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 077610-001 Oct 30, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Mylan Institutional AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 076217-001 Oct 15, 2002 AP RX No Yes   Start Trial   Start Trial   Start Trial
Wyeth Pharms Inc CORDARONE amiodarone hydrochloride INJECTABLE;INJECTION 020377-001 Aug 3, 1995 DISCN Yes No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma Ltd AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 204742-001 Jun 3, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Sandoz AMIODARONE HYDROCHLORIDE amiodarone hydrochloride TABLET;ORAL 075315-001 Dec 23, 1998 AB RX No Yes   Start Trial   Start Trial   Start Trial
Baxter Hlthcare NEXTERONE amiodarone hydrochloride INJECTABLE;INJECTION 022325-001 Dec 24, 2008 DISCN Yes No   Start Trial   Start Trial Y   Start Trial
Bedford AMIODARONE HYDROCHLORIDE amiodarone hydrochloride INJECTABLE;INJECTION 076018-001 Oct 15, 2002 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Colorcon
Mallinckrodt
Boehringer Ingelheim
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2020 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2020 - 2021
 NCE-1 Patent Challenge Dates 2020 - 2021
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2020, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group

DrugPatentWatch reviews